Dana-Farber Cancer Institute and Harvard University have launched a human trial to test a potential vaccine against melanoma, a deadly form of skin cancer. Don Ingber, founding director of the Wyss Institute for Biologically Inspired Engineering at Harvard and the Judah Folkman Professor of Vascular Biology at HMS, is quoted.
